# Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies

> **NCT00533078** · PHASE2 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 14 (actual)

## Conditions studied

- Colitis
- Mucositis
- AML

## Interventions

- **DIETARY_SUPPLEMENT:** omegaven

## Key facts

- **NCT ID:** NCT00533078
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533078, "Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00533078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*